The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of sequential androgen receptor pathway inhibitors (ARPIs) versus novel therapies in metastatic castration-resistant prostate cancer after progression on second-generation ARPIs: A systematic review and meta-analysis.
 
Rohan Garje
Honoraria - Novartis
Research Funding - Exelixis (Inst); Janssen Oncology (Inst)
 
Mohammad Arfat Ganiyani
No Relationships to Disclose
 
Gabriel Valagni
No Relationships to Disclose
 
Ahmad Iqbal
No Relationships to Disclose
 
Arjun Pon Avudaiappan
No Relationships to Disclose
 
Annabel Ricci
No Relationships to Disclose
 
Hiba Narvel
No Relationships to Disclose
 
Greeshma Nihitha Gaddipati
No Relationships to Disclose
 
Atulya Khosla
No Relationships to Disclose
 
Yashodhan Morye
No Relationships to Disclose
 
Karan Jatwani
Honoraria - Targeted Oncology
 
Deepak Kilari
Honoraria - Exelixis
Consulting or Advisory Role - Aptitude Health; Cardinal Health; Curio Science; Eisai; Exelixis; Foundation Medicine; IntegraConnect; Janssen Oncology; MJH Life Sciences; Pfizer
Speakers' Bureau - Astellas Pharma; AVEO; Eisai; Exelixis; Janssen; MJH Life Sciences
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Exelixis; Janssen
 
Murugesan Manoharan
No Relationships to Disclose